{"product_id":"discontinuing-antidepressant-medications-paperback-2","title":"Discontinuing Antidepressant Medications - Paperback","description":"\u003cdiv\u003e\u003cp style=\"text-align: right;\"\u003e\u003ca href=\"https:\/\/reportcopyrightinfringement.com\/\" target=\"_blank\" rel=\"nofollow\"\u003e\u003cb\u003eReport copyright infringement\u003c\/b\u003e\u003c\/a\u003e\u003c\/p\u003e\u003c\/div\u003e\u003cp\u003eby \u003cb\u003eGiovanni Fava\u003c\/b\u003e (Author)\u003c\/p\u003e\u003cp\u003eOne in six people in the US is currently taking psychotropic drugs. In 80% of cases, the medication is taken for long-term use and predominantly involves new-generation antidepressants, such as SSRIs (e.g. paroxetine) and SNRIs (e.g. venlafaxine). When patients want to stop taking these drugs and\/or their physicians decide it is time for them to stop, substantial problems often can ensue. About 50% of patients experience withdrawal symptoms that do not necessarily subside after a few days or weeks and may be severe and threatening. Physicians often do not know what to do in these situations. As a result, patients experiencing the anguish and mental pain of withdrawal syndromes are unlikely to receive appropriate medical attention. \u003c\/p\u003e\u003cp\u003e\u003c\/p\u003eDiscontinuing antidepressants is a highly technical challenge that requires specific strategies. This handbook guides clinicians through each clinical step (assessment; what the counter-indications would be for stopping or continuing; and how discontinuation can best be achieved). It provides a detailed account of the assessment and management strategies, with many case illustrations and clinical examples, drawing from the literature that is available and the extensive personal experience of the author.\u003cbr\u003e\u003ch3\u003eAuthor Biography\u003c\/h3\u003e\u003cp\u003e\u003cbr\u003eGiovanni Fava, \u003cem\u003eClinical Professor of Psychiatry, State University of New York, Buffalo, New York, USA\u003c\/em\u003e \u003c\/p\u003e\u003cp\u003e\u003c\/p\u003eGiovanni Andrea Fava, MD, is currently Clinical Professor of Psychiatry at the University of Buffalo, State University of New York. He has authored more than 500 scientific papers on depression, psychotherapy, psychopharmacology and psychosomatic medicine. He has introduced a novel\u003cbr\u003epsychotherapeutic approach (Well-Being Therapy. Basel, Karger, 2016), the sequential model for combining pharmacotherapy and psychotherapy, the concept of staging in psychiatry, the Diagnostic Criteria for Psychosomatic Research, and new methods of psychiatric evaluation. He is also\u003cbr\u003eeditor-in-chief of the top journal Psychotherapy and Psychosomatics. As an investigator, he has published groundbreaking research on antidepressant drug discontinuation . As an editor, he has published key papers that have suggested a reconsideration of the problem and modification of the\u003cbr\u003eguidelines.\u003cbr\u003e\n            \u003cdiv\u003e\n\u003cstrong\u003eNumber of Pages:\u003c\/strong\u003e 192\u003c\/div\u003e\n            \u003cdiv\u003e\n\u003cstrong\u003eDimensions:\u003c\/strong\u003e 0.41 x 8.77 x 5.58 IN\u003c\/div\u003e\n            \u003cdiv\u003e\n\u003cstrong\u003ePublication Date:\u003c\/strong\u003e January 28, 2022\u003c\/div\u003e\n            ","brand":"BooksCloud","offers":[{"title":"Default Title","offer_id":47339256774905,"sku":"9780192896643","price":82.06,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0789\/2782\/3097\/files\/R2pjcGtSWCtud0t3NzhPUHhDQ0VDdz09_ac32cb5c-3d00-4c9b-957d-c895b457a0d5.webp?v=1769689137","url":"https:\/\/bookscloud.io\/products\/discontinuing-antidepressant-medications-paperback-2","provider":"BooksCloud Book Dropshipping","version":"1.0","type":"link"}